UNII 368GB5141J

SODIUM LAURYL SULFATE

Unique Ingredient Identifier 368GB5141J is listed as a ingredient substance
Unii368GB5141J
Preferred Substance NameSODIUM LAURYL SULFATE
Rn151-21-3
Ec205-788-1
NcitC76733
Rxcui9871
Pubchem3423265
Molecular FormulaC12H25O4S.Na
InchikeyDBMJMQXJHONAFJ-UHFFFAOYSA-M
Smiles[Na+].CCCCCCCCCCCCOS([O-])(=O)=O
Unii TypeINGREDIENT SUBSTANCE
RN151-21-3
EC205-788-1
NCITC76733
RXCUI9871
PUBCHEM3423265
MFC12H25O4S.Na
INCHI KEYDBMJMQXJHONAFJ-UHFFFAOYSA-M
SMILES[Na+].CCCCCCCCCCCCOS([O-])(=O)=O

Alternate Names

Dosage Forms

UNII 368GB5141J SODIUM LAURYL SULFATE is commonly included in medications in the following forms.

RouteDosage FormPotency
BUCCALTABLET5.18 MG
BUCCALTABLET, EXTENDED RELEASE5.18 MG
BUCCAL/SUBLINGUALTABLET1.1 MG
DENTALGEL1.47 %
DENTALPASTE NA
INHALATIONPOWDER NA
ORALCAPSULE25.8 MG
ORALCAPSULE (IMMED./COMP. RELEASE), HARD GELATIN3.6 MG
ORALCAPSULE, DELAYED ACTION5.98 MG
ORALCAPSULE, DELAYED ACTION, COATED1 mg
ORALCAPSULE, DELAYED ACTION, COATED, HARD GELATIN2 MG
ORALCAPSULE, DELAYED ACTION, ENTERIC COATED NA
ORALCAPSULE, DELAYED RELEASE1 MG
ORALCAPSULE, ENTERIC COATED PELLETS0.6 MG
ORALCAPSULE, EXTENDED RELEASE16.67 MG
ORALCAPSULE, HARD GELATIN16.2 MG
ORALCAPSULE, SOFT GELATIN96 MG
ORALCAPSULE, SUSTAINED ACTION9.47 MG
ORALCAPSULE, SUSTAINED ACTION, HARD GELATIN3.75 MG
ORALDISPERSIBLE TABLET48 MG
ORALDROPS NA
ORALGRANULE6.2 mg
ORALPELLET0.264 MG
ORALPOWDER, FOR ORAL SUSPENSION0.48 MG/5ML
ORALPOWDER, FOR SUSPENSION3.3 MG/5ML
ORALSUSPENSION1.5 MG/1ML
ORALSUSPENSION, EXTENDED RELEASE0.02 MG/1ML
ORALTABLET51.69 MG
ORALTABLET (IMMED./COMP. RELEASE), COATED1 MG
ORALTABLET (IMMED./COMP. RELEASE), FILM COATED4.8 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE5 MG
ORALTABLET, CHEWABLE2 MG
ORALTABLET, COATED5.2 MG
ORALTABLET, CONTROLLED RELEASE0.48 mg
ORALTABLET, DELAYED ACTION4 MG
ORALTABLET, DELAYED ACTION, ENTERIC COATED8.09 MG
ORALTABLET, DELAYED RELEASE3 MG
ORALTABLET, EXTENDED RELEASE51.69 MG
ORALTABLET, FILM COATED20 MG
ORALTABLET, MULTILAYER, EXTENDED RELEASE0.8 MG
ORALTABLET, ORALLY DISINTEGRATING2 MG
ORALTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE0.5 mg
ORALTABLET, SUSTAINED ACTION20.62 MG
ORALTABLET, SUSTAINED ACTION, COATED10.5 MG
SUBLINGUALTABLET0.02 MG
TOPICALCREAM0.75 %W/W
TOPICALCREAM0.1 %W/W
TOPICALEMULSION, CREAM2.5 %W/W
TOPICALGEL0.05 %W/W
TOPICALLOTION0.5 %W/W
TOPICALOINTMENT1 %W/W
TOPICALSHAMPOO NA
TOPICALSHAMPOO, SUSPENSION40 %W/V
TOPICALSPONGE NA
TOPICALSPRAY0.1 %W/W
TOPICALSPRAY0.08 %W/V
VAGINALCREAM0.3 %W/W
VAGINALCREAM, EMULSION, SUSTAINED RELEASE0.3 %W/W
VAGINALEMULSION, CREAM0.33 %W/W
VAGINALINSERT5 MG
VAGINALTABLET5 MG

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.